Embecta earnings were $52.8M for the trailing 12 months ending Mar 31, 2025, with -26.2% growth year over year. The latest EMBC earnings report on Mar 31, 2025 announced Q1 2025 earnings of $23.5M, up Infinity% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, EMBC reported annual earnings of $78.3M, with 11.2% growth.
EMBC past earnings growth
How has EMBC's earnings growth performed historically?
On EMBC's earnings call on Invalid Date, Embecta (NASDAQ: EMBC) reported Q1 2025 earnings per share (EPS) of $0.40, up 20% year over year. Total EMBC earnings for the quarter were $23.50 million. In the same quarter last year, Embecta's earnings per share (EPS) was $0.50.
As of the last Embecta earnings report, Embecta is currently profitable. Embecta's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $52.80 million, a 24.79% decrease year over year.
What was EMBC's earnings growth in the past year?
As of Embecta's earnings date in Invalid Date, Embecta's earnings has grown -26.23% year over year. This is 42.46 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 16.24%. EMBC earnings in the past year totalled $52.80 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.